Literature DB >> 35091963

Involvement of Paired Immunoglobulin-like Receptor B in Diabetes-Associated Cognitive Dysfunction Through Modulation of Axon Outgrowth and Dendritic Remodeling.

Kairui Pu1, Meiyan Wu1, Tao Jiang1, Yuxin Zhang1, Mao Ye1, Jianyu Sun1, Hongli Ma1, Qian Zhai1, Qiang Wang2.   

Abstract

Type 2 diabetic patients have high risk of developing cognitive dysfunction, in which neural structural plasticity has played a pivotal role. Paired immunoglobulin-like receptor B (PirB), a receptor mainly expressed in neurons, acts as a critical inhibitor of neurite outgrowth and neural plasticity. However, the role of PirB in type 2 diabetes-associated cognitive dysfunction remains unknown. In this study, learning and memory impairment was observed in 24-week-old db/db mice by performing Morris water maze task, and the number of synapses along with the length of postsynaptic density by transmission electron microscopy were reduced in the hippocampus of db/db mice. Furthermore, PirB expression in the hippocampus of db/db mice was significantly upregulated using western blotting and immunofluorescence analysis. In cultured hippocampal neurons, high glucose treatment reduced the length of the longest neurite as well as axon initial segment (AIS), whereas silencing PirB expression rescued high glucose-induced neurite outgrowth inhibition, but not AIS. Additionally, cognitive deficits, dendrite morphology defects, and synapse-related proteins loss in db/db mice were alleviated when PirB knockdown was performed by adeno-associated virus injection. In conclusion, PirB is involved in diabetes-associated cognitive dysfunction through modulation of axon outgrowth and dendritic remodeling, providing a potential therapeutic target for diabetes-associated cognitive dysfunction.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cognitive dysfunction; Diabetes; Hippocampus; Neural structural plasticity; PirB

Mesh:

Substances:

Year:  2022        PMID: 35091963     DOI: 10.1007/s12035-021-02679-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  43 in total

Review 1.  Neural plasticity in the ageing brain.

Authors:  Sara N Burke; Carol A Barnes
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

Review 2.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

Review 3.  Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities.

Authors:  Velandai Srikanth; Alan J Sinclair; Felicia Hill-Briggs; Chris Moran; Geert Jan Biessels
Journal:  Lancet Diabetes Endocrinol       Date:  2020-06       Impact factor: 32.069

4.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

5.  Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.

Authors:  Alexis M Stranahan; Kim Lee; Bronwen Martin; Stuart Maudsley; Erin Golden; Roy G Cutler; Mark P Mattson
Journal:  Hippocampus       Date:  2009-10       Impact factor: 3.899

6.  Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons.

Authors:  Alexis M Stranahan; Thiruma V Arumugam; Roy G Cutler; Kim Lee; Josephine M Egan; Mark P Mattson
Journal:  Nat Neurosci       Date:  2008-02-17       Impact factor: 24.884

Review 7.  Effects of diabetes on hippocampal neurogenesis: links to cognition and depression.

Authors:  Nancy Ho; Marilyn S Sommers; Irwin Lucki
Journal:  Neurosci Biobehav Rev       Date:  2013-05-13       Impact factor: 8.989

8.  ZiBuPiYin recipe protects db/db mice from diabetes-associated cognitive decline through improving multiple pathological changes.

Authors:  Jing Chen; Lina Liang; Libin Zhan; Yan Zhou; Luping Zheng; Xiaoxin Sun; Jin Gong; Hua Sui; Rujiao Jiang; Fuliang Zhang; Lin Zhang
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 9.  Synapses in neurodegenerative diseases.

Authors:  Jae Ryul Bae; Sung Hyun Kim
Journal:  BMB Rep       Date:  2017-05       Impact factor: 4.778

10.  Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records.

Authors:  Jonathan Pearson-Stuttard; James Bennett; Yiling J Cheng; Eszter P Vamos; Amanda J Cross; Majid Ezzati; Edward W Gregg
Journal:  Lancet Diabetes Endocrinol       Date:  2021-02-04       Impact factor: 44.867

View more
  1 in total

1.  Identification and Experimental Validation of Marker Genes between Diabetes and Alzheimer's Disease.

Authors:  Cheng Huang; Xueyi Wen; Hesong Xie; Di Hu; Keshen Li
Journal:  Oxid Med Cell Longev       Date:  2022-08-12       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.